Tenet Healthcare Corporation THC
283.95 USD -8.30 (-2.84%)
Nov 5, 2026, 12:17 PM EST
283.95 Day range 301.44
157.58 52-week range 301.44
- YTD
- +42.89%
- 1 year
- +36.11%
News
benzinga.com Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $297 Barclays analyst Andrew Mok maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $271 to $297.
barrons.com Healthcare Stocks Bounce on Midterm Results. A Bull Market Case Is Developing. The stocks of big operators in state Medicaid programs, Affordable Care Act markets and hospital groups all jumped.
zacks.com Tenet Healthcare Corporation (THC) Is a Trending Stock: Facts to Know Before Betting on It Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
benzinga.com Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $305 Truist Securities analyst David Macdonald reiterates Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $290 to $305.- benzinga.com Keybanc Maintains Overweight on Tenet Healthcare, Raises Price Target to $300 Keybanc analyst Matthew Gillmor maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $270 to $300.
- benzinga.com Leerink Partners Maintains Outperform on Tenet Healthcare, Raises Price Target to $342 Leerink Partners analyst Whit Mayo maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $309 to $342.
benzinga.com RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $304 RBC Capital analyst Ben Hendrix maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $283 to $304.- benzinga.com Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $321 Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $281 to $321.
marketbeat.com Tenet Healthcare Q3 Earnings Call Highlights Tenet Healthcare NYSE: THC reported third-quarter 2026 net operating revenue of $5.6 billion and consolidated adjusted EBITDA of $1.355 billion, while adjusted diluted earnings per share rose 80%…
zacks.com THC Q3 Earnings Call Highlights Higher Outlook and Margin Gains Tenet Healthcare raises its 2026 outlook as Q3 earnings surge, hospital margins improve and higher-acuity care drives ambulatory growth despite payer pressures.
benzinga.com Guggenheim Maintains Buy on Tenet Healthcare, Lowers Price Target to $306 Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and lowers the price target from $307 to $306.
zacks.com THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View Raised Tenet Healthcare's Q3 earnings surge 79.5% on strong hospital performance and cost discipline, prompting higher 2026 EPS and EBITDA guidance.
seekingalpha.com Tenet Healthcare Corporation (THC) Q3 2026 Earnings Call Transcript Tenet Healthcare Corporation (THC) Q3 2026 Earnings Call Transcript
zacks.com Tenet (THC) Reports Q3 Earnings: What Key Metrics Have to Say The headline numbers for Tenet (THC) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street…
benzinga.com Tenet Healthcare Q3 2026 Earnings Call Transcript Tenet Healthcare (NYSE:THC) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
zacks.com Tenet Healthcare (THC) Surpasses Q3 Earnings and Revenue Estimates Tenet Healthcare (THC) came out with quarterly earnings of $6.64 per share, beating the Zacks Consensus Estimate of $4.6 per share. This compares to earnings of $3.7 per share a year ago.
benzinga.com Tenet Healthcare Raises FY2026 Adj EPS Guidance from $20.30-$21.69 to $22.05-$23.01 vs $21.01 Est; Narrows FY2026 Sales Guidance from $21.900B-$22.500B to $22.050B-$22.450B vs $22.351B Est Tenet Healthcare (NYSE:THC) raises FY2026 Adj EPS guidance from $20.30-$21.69 to $22.05-$23.01 vs $21.01 analyst estimate. Narrows FY2026 sales outlook from $21.900 billion-$22.500 billion to $22.050…- benzinga.com Tenet Healthcare Raises FY2026 GAAP EPS Guidance from $34.57-$36.43 to $35.82-$37.08 vs $33.03 Est Tenet Healthcare (NYSE:THC) raises FY2026 GAAP EPS guidance from $34.57-$36.43 to $35.82-$37.08 vs $33.03 analyst estimate..
businesswire.com Tenet Reports Strong Third Quarter 2026 Results; Raises 2026 Financial Outlook DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended September 30, 2026. "Our outperformance in the third quarter of 2026 was…
zacks.com Here's Why Tenet Healthcare (THC) is a Strong Value Stock The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zacks.com Can Tenet Healthcare Beat Q3 Earnings on Ambulatory Care Strength? Can THC deliver a Q3 earnings beat? Ambulatory Care growth and higher revenues per adjusted admission offer support, but hospital volume declines and costs loom.
zacks.com Here's Why Tenet Healthcare (THC) is a Strong Momentum Stock The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zacks.com Insights Into Tenet (THC) Q3: Wall Street Projections for Key Metrics Get a deeper insight into the potential performance of Tenet (THC) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for…
defenseworld.net Tenet Healthcare Corporation $THC Stake Boosted by Diversify Advisory Services LLC Diversify Advisory Services LLC grew its holdings in Tenet Healthcare Corporation (NYSE: THC) by 35.7% during the undefined quarter, according to its most recent Form 13F filing with the Securities…
zacks.com Will Tenet (THC) Beat Estimates Again in Its Next Earnings Report? Tenet (THC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
zacks.com Tenet Healthcare (THC) Earnings Expected to Grow: Should You Buy? Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
seekingalpha.com Tenet Healthcare: Hospital Margins Are Improving Faster Than The Market May Expect Tenet Healthcare is rated Buy, driven by robust Q2 results, margin expansion, and attractive valuation at 12.7x forward EPS. Hospital segment EBITDA margin surged to 18%, with adjusted EBITDA up…
zacks.com Tenet Healthcare (THC) Stock Dips While Market Gains: Key Facts In the most recent trading session, Tenet Healthcare (THC) closed at $269.13, indicating a -1.17% shift from the previous trading day.
zacks.com Investors Heavily Search Tenet Healthcare Corporation (THC): Here is What You Need to Know Recently, Zacks.com users have been paying close attention to Tenet (THC). This makes it worthwhile to examine what the stock has in store.
defenseworld.net Tenet Healthcare Corporation $THC Stock Bought by CWA Asset Management Group LLC CWA Asset Management Group LLC grew its stake in shares of Tenet Healthcare Corporation (NYSE: THC) by 8.8% in the third quarter, according to the company in its most recent 13F filing with the…- benzinga.com Guggenheim Maintains Buy on Tenet Healthcare, Raises Price Target to $307 Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $283 to $307.
benzinga.com $1000 Invested In Tenet Healthcare 15 Years Ago Would Be Worth This Much Today Tenet Healthcare (NYSE:THC) has outperformed the market over the past 15 years by 6.23% on an annualized basis producing an average annual return of 19.49%. Currently, Tenet Healthcare has a market…- benzinga.com FTC Issues Letters Warning Hospitals Against Deceptive Pricing Practices https://www.ftc.gov/news-events/news/press-releases/2026/10/ftc-issues-letters-warning-hospitals-against-deceptive-pricing-practices
benzinga.com Here’s How Much You Would Have Made Owning Tenet Healthcare Stock In The Last 10 Years Tenet Healthcare (NYSE:THC) has outperformed the market over the past 10 years by 14.65% on an annualized basis producing an average annual return of 28.19%. Currently, Tenet Healthcare has a market…
benzinga.com Junk Bond Yields Are Back Above 15%: 10 Stocks In The Pressure Zone Junk bond yields surpassed 15%, the highest since 2022. These 10 stocks with bonds in XCCC carry $97 billion of debt as higher rates bite.
benzinga.com BMO Capital Initiates Coverage On Tenet Healthcare with Market Perform Rating, Announces Price Target of $265 BMO Capital analyst Sean Dodge initiates coverage on Tenet Healthcare (NYSE:THC) with a Market Perform rating and announces Price Target of $265.- benzinga.com $100 Invested In Tenet Healthcare 5 Years Ago Would Be Worth This Much Today Tenet Healthcare (NYSE:THC) has outperformed the market over the past 5 years by 17.9% on an annualized basis producing an average annual return of 29.4%. Currently, Tenet Healthcare has a market…
- benzinga.com If You Invested $100 In Tenet Healthcare Stock 10 Years Ago, You Would Have This Much Today Tenet Healthcare (NYSE:THC) has outperformed the market over the past 10 years by 14.22% on an annualized basis producing an average annual return of 27.62%. Currently, Tenet Healthcare has a market…
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…- benzinga.com Here’s How Much You Would Have Made Owning Tenet Healthcare Stock In The Last 15 Years Tenet Healthcare (NYSE:THC) has outperformed the market over the past 15 years by 5.42% on an annualized basis producing an average annual return of 18.6%. Currently, Tenet Healthcare has a market…
benzinga.com Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $281 Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $231 to $281.
benzinga.com Top 3 Health Care Stocks That May Implode This Month RSI warning: 3 overbought health care stocks could be flashing a real warning to investors with high momentum trading preferences- benzinga.com Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $290 Truist Securities analyst David Macdonald maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $270 to $290.
benzinga.com Twilio To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Tuesday Top Wall Street analysts changed their outlook on top names. For a complete view, see analyst ratings page. See how others view these stocks.- benzinga.com Baird Maintains Neutral on Tenet Healthcare, Raises Price Target to $280 Baird analyst Michael Ha maintains Tenet Healthcare (NYSE:THC) with a Neutral and raises the price target from $210 to $280.
- benzinga.com Guggenheim Maintains Buy on Tenet Healthcare, Raises Price Target to $283 Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $242 to $283.
benzinga.com UBS Maintains Buy on Tenet Healthcare, Raises Price Target to $308 UBS analyst A.J. Rice maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $288 to $308.- benzinga.com TD Cowen Maintains Buy on Tenet Healthcare, Raises Price Target to $263 TD Cowen analyst Ryan Langston maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $233 to $263.
benzinga.com Morgan Stanley Maintains Overweight on Tenet Healthcare, Raises Price Target to $274 Morgan Stanley analyst Craig Hettenbach maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $254 to $274.- benzinga.com RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $283 RBC Capital analyst Ben Hendrix maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $236 to $283.